AUPH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Aurinia Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 15.31 USD -0.13%

Market Cap: $2B

	Aurinia Pharmaceuticals Inc NASDAQ:AUPH	CA
	Tsuruha Holdings Inc TSE:3391	JP
F	Fluor Corp DUS:FLU	US
	Tesla Inc MIL:1TSLA	US
	Lynas Rare Earths Ltd ASX:LYC	MY
S	Storagevault Canada Inc TSX:SVI	CA
	Pennant International Group PLC LSE:PEN	UK
C	Cafe24 Corp KOSDAQ:042000	KR
C	CENIT AG SWB:CSH	DE

Profitability Summary

Aurinia Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

90%

Declining Gross Margin

96% > 90%

Exceptional Operating Margin

42%

Negative 3Y Average Operating Margin

-6%

Operating Margin is Increasing

-70% > 42%

Exceptional Net Margin

100%

Low 3Y Average Net Margin

Net Margin is Increasing

-66% > 100%

Exceptional Free Cash Flow Margin

56%

Strong 3Y Average Free Cash Flow Margin

13%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.